idoxuridine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tomilin, N | 1 |
| Rosanov, Yu | 1 |
| Zenin, V | 1 |
| Bozhkov, V | 1 |
| Vig, B | 1 |
| Hegde, U | 1 |
| Kotelnikov, VM | 1 |
| Handa, H | 1 |
| Burke, P | 1 |
| Preisler, HD | 1 |
2 other studies available for idoxuridine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
A new and rapid method for visualising DNA replication in spread DNA by immunofluorescence detection of incorporated 5-iododeoxyuridine.
Topics: Chromosomes, Human; DNA; DNA Replication; DNA, Neoplasm; Floxuridine; Fluorescent Antibody Technique | 1993 |
Accuracy of immunohistochemistry and flow cytometry in estimating the proportion of leukemic cells in S phase in chronic myeloid leukemia patients.
Topics: Antibodies, Monoclonal; Biopsy, Needle; Blast Crisis; Bone Marrow; Cell Division; Flow Cytometry; Fl | 1996 |